Wikidata

(Q64216897)

English

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study

clinical trial

In more languages

Statements

short name
STEADFAST (English)
0 references
title
Multicenter, Safety and Efficacy, Open-Label Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia (English)
0 references
medical condition
Friedreich ataxia
0 references
ataxia
0 references
cerebellar ataxia
0 references
start time
25 December 2015
0 references
end time
21 March 2017
0 references
number of participants
86
0 references
minimum age
10 year
0 references
maximum age
26 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64216897&oldid=1857622773"